Skip to main content
OpenTrials

Clinical trial condition

Primary Immune Deficiency

Explore clinical trials studying Primary Immune Deficiency. Study availability and eligibility vary by location and protocol.

17 public trials 3 recruiting studies
Refine in advanced search Browse all conditions

Primary Immune Deficiency trial results

Completed

Extension Study of Subcutaneous Immunoglobulin Human in Patients With Primary Immunodeficiency (PID)

NCT00719680

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Contact CSL Behring for facility details Centennial, Colorado, United States
  • Contact CSL Behring for facility details North Palm Beach, Florida, United States
  • Contact CSL Behring for facility details Indianapolis, Indiana, United States
  • Contact CSL Behring for facility details Dallas, Texas, United States
View Trial Details
Completed

Safety Study of Subcutaneous Ig NextGen 16% in Patients With Primary Immunodeficiency

NCT00680446

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Campbelltown Hospital Campbelltown, New South Wales, Australia
  • Sydney Children's Hospital Randwick, New South Wales, Australia
  • Royal Adelaide Hospital Adelaide, South Australia, Australia
  • Women's & Children's Hospital North Adelaide, South Australia, Australia
View Trial Details
Completed

Study of Subcutaneous Immunoglobulin in Patients With PID Requiring IgG Replacement Therapy

NCT00419341

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Study Site Los Angeles, California, United States
  • Study Site Los Angeles, California, United States
  • Study Site Centennial, Colorado, United States
  • Study Site North Palm Beach, Florida, United States
View all 13 locations
View Trial Details
Completed

Retrospective Chart Review of Subcutaneous IgG Use in Infants

NCT01166074

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Children's Hospital of Los Angeles Los Angeles, California, United States
  • University of South Florida Tampa, Florida, United States
  • Midwest Immunology Clinic Plymouth, Minnesota, United States
  • University Hospitals Case Medical Center Cleveland, Ohio, United States
View Trial Details
Active, Not Recruiting

Study to Evaluate the Pharmacokinetics, Efficacy, Tolerability, and Safety of Subcutaneous Human Immunoglobulin (Newnorm) in Patients With Primary Immunodeficiency Diseases

NCT04640142

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Octapharma Research Site Irvine, California, United States
  • Octapharma Research Site Centennial, Colorado, United States
  • Octapharma Research Site Port Saint Lucie, Florida, United States
  • Octapharma Research Site St. Petersburg, Florida, United States
View all 23 locations
View Trial Details
Active, Not Recruiting

Study of Immune Globulin Intravenous (Human) GC5107 in Pediatric Subjects With Primary Humoral Immunodeficiency

NCT04565015

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Immune System Diseases, +3 more
Locations
  • Children's Hospital Colorado Aurora, Colorado, United States
  • Immunoe Health & Research Centers Centennial, Colorado, United States
  • Allergy Partners of North Texas Research Dallas, Texas, United States
  • Lysosomal and Rare Disorders Research and Treatment Center, Inc. Fairfax, Virginia, United States
View Trial Details
Active, Not Recruiting

COVID-19 Vaccine Responses in PIDD Subjects

NCT05321407

Conditions
Bruton type agammaglobulinemia, COVID-19, CVID, +22 more
Locations
  • University of South Florida St. Petersburg, Florida, United States
  • University of North Carolina, Chapel Hill Chapel Hill, North Carolina, United States
  • Duke University Durham, North Carolina, United States
View Trial Details

Related conditions